Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin after shockwave lithotripsy for urolithiasis
ACTRN12616001718437Phase 3Not yet recruiting
- Sponsor
- Monash Health
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tamsulosin in Lithiasis (2 arms), sponsored by Monash Health. Primary endpoint: Stone passage rate. Planned start Apr 2017; status: not yet recruiting.
02
Drugs
tamsulosin
03
Conditions
Lithiasis
Beyond the preview
Go deeper on ACTRN12616001718437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001718437.